Oral Swab Xpert MTB/RIF Ultra for Tuberculosis Diagnosis in Ethiopian Prisons

This study demonstrates that oral swab Xpert MTB/RIF Ultra testing, using a customized processing protocol, is a feasible and moderately sensitive non-invasive diagnostic tool for detecting tuberculosis in high-burden Ethiopian prisons, particularly for cases with medium-to-high bacillary loads.

The Gist

The Big Picture: A Hidden Epidemic in a Locked Room

Imagine a prison as a giant, crowded room where the air doesn't circulate well. In countries like Ethiopia, this room is a perfect breeding ground for Tuberculosis (TB), a deadly lung disease. The problem? The prison guards (and doctors) are trying to find the "bad guys" (TB bacteria) using a method that often fails: asking people to cough up mucus (sputum) into a cup.

The Problem:
Many people with TB, especially those in the early stages or those who are very sick, simply cannot cough up mucus. It's like trying to find a needle in a haystack, but the person holding the haystack is empty-handed. Because they can't produce the sample, they go undiagnosed, stay sick, and keep spreading the disease to their cellmates.

The New Idea: The "Oral Swab" Detective

The researchers asked: If we can't get the mucus from the lungs, can we find the bacteria somewhere else?

They decided to try Oral Swab Analysis (OSA). Instead of asking for a deep cough, they simply took a swab (like a giant Q-tip) and brushed it against the inmates' tongues.

The Analogy:
Think of the bacteria as tiny, invisible dust motes floating in the air. When a person breathes, these dust motes settle on their tongue, just like dust settles on a windowsill. The researchers hypothesized that if they swabbed the "windowsill" (the tongue), they could catch the dust (the bacteria) without needing the person to cough.

The Experiment: Testing the New Tool

The team went into three Ethiopian prisons and detention centers. They looked at over 8,000 men. They found 221 men who had a cough and asked them to do two things:

1. The Old Way: Cough up mucus (sputum) for a standard lab test.
2. The New Way: Let the researchers swab their tongues.

They used a high-tech machine called Xpert MTB/RIF Ultra to analyze both samples. This machine is like a super-sensitive metal detector that can find even a single speck of the TB bacteria.

The Twist:
The standard way of processing the tongue swab wasn't working well. It was like trying to wash a dirty dish with too much water; the "dirt" (bacteria) got washed away and diluted before the machine could see it.

So, the researchers created a custom recipe. They used a specific mixture of chemicals (Sample Reagent) that was less watery. This was like using a concentrated soap instead of a bucket of water to clean the dish, ensuring the bacteria stayed visible to the machine.

The Results: How Did It Work?

Here is what they found:

• The "Heavy" Cases: For inmates with a lot of bacteria (high "bacillary load"), the tongue swab was perfect. It caught 100% of them.
  • Analogy: If the room is filled with smoke, a simple air sensor will definitely go off.
• The "Light" Cases: For inmates with very few bacteria (low load), the swab missed about 40% of them.
  • Analogy: If there is only a tiny wisp of smoke, the sensor might not notice it.
• The "Trace" Cases: The swab completely missed the cases where the bacteria were barely detectable (labeled "trace").
• No False Alarms: When the swab said "TB Found," it was always correct (100% specificity). It never falsely accused a healthy person.

The Verdict:
The tongue swab isn't a perfect replacement for the cough test yet, but it's a great backup plan. It found about 62% of the TB cases that the standard test found, but it did so without requiring the patient to cough.

Why This Matters

1. It's Easier: Imagine trying to get a shy, scared, or very sick person to cough into a cup in a noisy, crowded prison. It's hard. Swabbing a tongue is quick, painless, and less embarrassing.
2. It Catches the "Silent" Spreaders: Many people with TB don't have a bad cough yet, but they are still spreading the disease. The swab can catch these people earlier than waiting for them to get sick enough to cough.
3. It's Feasible: The study proved that this method works in real-world prisons, not just in a fancy lab.

The Bottom Line

The researchers concluded that using a tongue swab with this special "custom recipe" is a powerful new tool for fighting TB in prisons.

Think of it this way:
If the standard cough test is a fishing net that only catches big fish, the oral swab is a magnet that can pick up smaller fish that the net misses. While the magnet doesn't catch every fish (especially the tiny ones), it catches enough to make a huge difference in keeping the prison (and the community outside) safe.

The Takeaway: By adding this simple, non-invasive swab to their toolkit, prison health workers can find more sick people, treat them faster, and stop the spread of TB before it becomes an outbreak.

Technical Summary

1. Problem Statement

• High TB Burden in Prisons: Incarcerated populations in high-burden countries like Ethiopia face disproportionately high rates of Tuberculosis (TB), with prevalence in Ethiopian prisons reaching 9.8% (compared to the general population). Prisons act as amplifiers for transmission, posing risks to inmates, staff, and the wider community.
• Diagnostic Gaps: Current TB diagnosis in these settings relies heavily on sputum-based testing. This approach fails to detect cases in individuals who cannot produce sputum (due to lack of symptoms or physiological inability) or those with subclinical/asymptomatic disease.
• Limitations of Existing Non-Invasive Methods: While Oral Swab Analysis (OSA) using Xpert MTB/RIF Ultra (Ultra) is a promising non-invasive alternative, its performance has been variable. Standard protocols designed for sputum (using a 2:1 Sample Reagent-to-sample ratio) often result in over-dilution of oral specimens, leading to reduced DNA recovery and suboptimal sensitivity, particularly for low-bacillary-load cases.
• Lack of Data in SSA Prisons: There is a critical lack of systematic evaluation of OSA with Ultra specifically within prison settings in Sub-Saharan Africa (SSA), where diagnostic needs are most acute.

2. Methodology

• Study Design: A cross-sectional diagnostic accuracy study conducted between January and October 2025.
• Setting: Three facilities in Ethiopia: Kality Federal Prison, Ziway Prison, and Kilinto Detention Center (Addis Ababa and surrounding areas).
• Population: 858 incarcerated men (≥18 years) screened; 221 eligible participants with cough of any duration were included in the final analysis. Women were excluded due to logistical constraints.
• Sample Collection:
  • Oral Swabs: Two swabs per participant (early-morning and spot swab 30 minutes later) collected from the mid-dorsum of the tongue using FLOQSwabs. Swabs were stored in Tris-EDTA-Tween (TET) buffer.
  • Sputum: Two consecutive morning sputum samples collected.
• Laboratory Processing (Key Innovation):
  • Oral Swab Protocol: A customized 2:1 Sample Reagent (SR) to sample ratio was used. Specifically, 466 µL of SR was added to 234 µL of TET buffer containing the swabs (total volume 700 µL), resulting in a final SR concentration of 16.6%. This was optimized to improve DNA recovery compared to the standard sputum protocol (66.7% SR).
  • Testing: Samples were tested using Xpert MTB/RIF Ultra.
  • Reference Standard: A composite Microbiological Reference Standard (MRS) comprising Sputum Xpert Ultra and Mycobacteria Growth Indicator Tube (MGIT) liquid culture.
• Statistical Analysis: Sensitivity, specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV) were calculated against both Sputum Ultra and the composite MRS.

3. Key Contributions

• Protocol Optimization: The study validated a modified sample processing protocol for oral swabs (lowering the final SR concentration to 16.6%) which analytically improves the Limit of Detection (LoD) to 30.3 CFU/700 µL, significantly better than previous standard protocols.
• Dual-Swab Strategy: Implementation of a dual-swab collection method (morning + spot) to ensure adequate bacterial load and replenishment of M. tuberculosis on the tongue surface.
• Real-World Validation: First systematic evaluation of this optimized OSA protocol in high-burden Ethiopian prison settings, addressing a critical gap in TB control literature for correctional facilities.
• Operational Feasibility: Demonstrated that non-invasive oral swabbing is logistically feasible and acceptable in prison environments where sputum collection is often hindered by stigma, lack of space, and inability to produce sputum.

4. Results

• Prevalence: Among the 221 analyzed participants, 34 (15.4%) were diagnosed with pulmonary TB based on the composite MRS.
• Diagnostic Accuracy (vs. Composite MRS):
  • Sensitivity: 61.8% (21/34 cases detected).
  • Specificity: 100% (187/187 non-cases correctly identified).
  • PPV: 100%; NPV: 93.5%.
• Diagnostic Accuracy (vs. Sputum Ultra only):
  • Sensitivity: 63.6% (21/33).
  • Specificity: 100%.
• Performance by Bacillary Load:
  • High/Medium Load: 100% sensitivity (9/9 cases detected).
  • Low/Very Low Load: 81% and 50% sensitivity, respectively.
  • Trace Load: 0% sensitivity (0/7 cases detected). None of the "trace" positive sputum cases were identified by oral swab.
• Symptom Correlation: Sensitivity was higher in patients with more TB symptoms. Patients with high bacillary loads had a mean of 4.1 symptoms, while those with trace loads had 3.8.
• Ct Values: Oral swab samples generally had higher (later) Cycle Threshold (Ct) values than sputum (median difference of 4.0 cycles), indicating lower bacterial load, though the difference was not statistically significant in this cohort.

5. Significance and Implications

• Complementary Tool: Oral swab Xpert Ultra is a viable, non-invasive complementary tool for TB screening in prisons. Its 100% specificity means positive results are highly reliable for initiating treatment.
• Addressing Paucibacillary Disease: While it missed "trace" cases, the test detected 70.6% of patients with low/very low bacillary loads, suggesting utility for subclinical cases that are often missed by passive sputum screening.
• Operational Impact: The ability to use oral swabs reduces the need for dedicated sputum collection spaces, lowers infection control risks associated with coughing in confined areas, and reduces stigma, potentially increasing participation in screening programs.
• Policy Recommendation: The authors recommend integrating oral swab Ultra into prison TB control programs, particularly for active case finding among new entrants and residents. However, they note that further optimization is needed to detect "trace" bacillary loads to fully capture asymptomatic transmission risks.
• Public Health Impact: Early detection of the 15.4% prevalence rate found in this study highlights the failure of current passive case-finding methods and underscores the urgent need for systematic active screening to interrupt transmission chains within prisons and the broader community.